SLDX.US JMD Properties Inc
- Market cap
- USD 3.02M
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is SLDX.US undervalued?
Graham numberThe Graham number of JMD Properties Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
JMD Properties Inc fundamental analysis
No fundamental analysis for JMD Properties Inc yet.
JMD Properties Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About JMD Properties Inc
Stella Diagnostics, Inc., a research diagnostics company, engages in developing molecular diagnostics tools and new drug targets for esophageal diseases. It uses targeted mass spectrometry to determine the level of disease progression in tissue of the lower esophagus. The company's technology informs gastroenterologists, surgical oncologists, and pathologists, which patients are high risk for disease progression into precancer or cancer. The company was formerly known as JMP…
Full company profileJMD Properties Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
JMD Properties Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2015 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | - | 146K | 6.02K | - | - | - | - | - | 1.78M | 1.36M |
| Gross Profit | - | - | 146K | 6.02K | - | - | - | - | - | -660K | -162K |
| Operating Income | -44.0K | -5.39K | -738K | -819K | -165K | -4.74M | -2.45M | -11.4M | -1.01M | -3.45M | -3.83M |
| EBITDA | -44.0K | -5.39K | -738K | -819K | -42.7K | -16.1M | -5.10M | -5.54M | -1.24M | -3.45M | -3.83M |
| Net Income | -44.2K | -5.39K | -1.80M | -1.08M | -262K | -16.6M | -5.64M | -5.71M | -1.24M | -4.06M | -4.14M |
| EPS | -0.30 | -1,647 | -936 | -0.01 | 0.00 | -0.17 | -0.03 | -0.02 | 0.00 | -0.01 | -0.01 |
| Balance Sheet | |||||||||||
| Total Assets | 1.12M | 1.13M | 611K | 612K | 39.8K | 1.83K | 1.78K | 472K | 189K | 172K | 113K |
| Total Liabilities | 1.52M | 1.67M | 5.15M | 6.21M | 10.6M | 213M | 22.0M | 18.0M | 19.0M | 27.0M | 29.1M |
| Shareholders' Equity | -393K | -614K | -4.54M | -5.60M | -10.5M | -213M | -22.0M | -17.5M | -18.8M | -26.9M | -28.9M |
| Cash & Short-term Investments | -6.00 | 1.00 | 10.00 | 733.00 | 37.5K | 1.25K | 1.20K | 7.63K | 4.91K | 58.0K | 7.92K |
| Total Debt | 1.05M | 1.10M | 1.56M | 1.60M | 1.33M | 7.04M | 7.96M | 6.20M | 6.64M | 12.5M | 14.1M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -4.24K | -19.9K | 39.1K | -41.2K | -163K | -355K | -268K | -1.68M | -57.7K | -1.30M | -3.38M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 4.00 | 0.00 | 0.00 | 1.00 | 4.00 | 0.00 | 0.00 |
| Free Cash Flow | -4.24K | -19.9K | 39.1K | -41.2K | -163K | -355K | -268K | -1.68M | -57.7K | -1.30M | -3.38M |
| Ratios | |||||||||||
| ROA | -3.9% | -0.5% | -295.3% | -176.9% | -658.3% | -908,821.7% | -316,544.3% | -1,208.1% | -652.9% | -2,354.3% | -3,654.9% |
| Net Profit Margin | - | - | -1,239.8% | -17,985.0% | - | - | - | - | - | -227.5% | -305.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
JMD Properties Inc dividends
JMD Properties Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:50000 on Mar 11, 2019.
Who owns JMD Properties Inc
Ownership data of JMD Properties Inc is not available yet.
JMD Properties Inc company profile
- Company name
- JMD Properties Inc
- Ticker
- SLDX.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Biotechnology
- Fiscal year end
- December
- Address
- 50 West Broadway, Salt Lake City, UT, United States, 84101
- Phone
- 201 381 1474
- Website
- stelladx.com
About JMD Properties Inc
Stella Diagnostics, Inc., a research diagnostics company, engages in developing molecular diagnostics tools and new drug targets for esophageal diseases. It uses targeted mass spectrometry to determine the level of disease progression in tissue of the lower esophagus. The company's technology informs gastroenterologists, surgical oncologists, and pathologists, which patients are high risk for disease progression into precancer or cancer. The company was formerly known as JMP Properties, Inc. and changed its name to Stella Diagnostics, Inc. in April 2021. Stella Diagnostics, Inc. is headquartered in Salt Lake City, Utah.
JMD Properties Inc management
1- Mr. David B. SeaburgCEO & Director · born 1970